Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting
MWN-AI** Summary
Aurora Spine Corporation, based in Carlsbad, California, has announced its participation in the 2025 North American Spine Society (NASS) Annual Meeting from November 14-16, 2025, at the Colorado Convention Center in Denver. Notable for its pioneering medical devices for spinal surgery, Aurora Spine will exhibit at Booth #1622. The NASS Annual Meeting is a premier global event that brings together spine professionals, providing an ideal venue for Aurora to showcase its advancements.
At this year’s meeting, Aurora will debut its state-of-the-art Hydra ANATOMIC. ELEVATED. RIGID. OSTEOFIXATION Facet Fusion System designed for treating facet joint-related pain and instability. Additionally, the company plans to present DEXA-L, a pioneering stand-alone device for anterior lumbar interbody fusion (ALIF) procedures, part of its innovative DEXA™ Technology Platform. DEXA™ technology personalizes spinal care by creating patient-matched implants that align with individual bone density and T-Score.
Trent Northcutt, President and CEO, expressed enthusiasm about the event and highlighted the company's commitment to advancing spinal surgery through innovative technologies. Laszlo Garamszegi, Chief Technology Officer, emphasized that the DEXA-L implant is unique and mimics bone structure, aiding surgeons in matching implants to patients’ bone characteristics.
Visitors to Booth #1622 can expect live demonstrations and discussions on how these forward-thinking innovations are set to transform spinal surgery. Aurora Spine focuses on developing minimally invasive, regenerative spinal implant solutions, contributing to a new era of tailored patient care.
For more information, Aurora Spine encourages attendees to visit its website. However, the company cautions that statements regarding product effectiveness are forward-looking and subject to uncertainties.
MWN-AI** Analysis
Aurora Spine Corporation (TSXV: ASG) is positioning itself as an innovative leader in the spinal surgery market, particularly amid its participation at the North American Spine Society (NASS) Annual Meeting. With the launch of its groundbreaking Hydra ANATOMIC Facet Fusion System and the DEXA-L anterior lumbar interbody fusion device, the company is poised to address significant pain management and surgical efficiency needs.
Investment in Aurora Spine could be attractive given the emphasis on personalized medical devices tailored to individual bone density, an area gaining traction in modern medicine. The DEXA-L, touted as the first bone-mimicking structural implant, presents a compelling offering that differentiates Aurora from competitors. Innovations showcased at industry events such as NASS provide a marketing platform to reach vital stakeholders, often fostering future partnerships and sales opportunities.
However, potential investors should approach with caution. The press release acknowledges substantial risks, with forward-looking statements highlighting uncertainties that could affect actual product performance. It’s crucial for stakeholders to carefully consider these factors against Aurora’s growth potential in a competitive field.
Furthermore, market trends indicate a growing demand for minimally invasive surgical solutions which aligns well with Aurora's product offerings. This trend, complemented by advancements in spinal surgery technology, could propel Aurora’s growth trajectory.
In conclusion, while Aurora Spine exhibits robust potential driven by innovative developments expected to resonate positively within the market, investors should weigh the inherent risks and uncertainties. Keeping a close eye on the company's performance post-NASS can provide further clarity on its trajectory and impact on shareholder value. A targeted investment strategy may include monitoring trade volumes and price movements following the event to gauge market sentiment.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Company to Showcase Cutting-Edge Innovations at Booth #1622
CARLSBAD, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced its participation at the 2025 North American Spine Society ("NASS") Annual Meeting. The event will take place from November 14-16, 2025, at the Colorado Convention Center, in Denver, Colorado. Aurora Spine will be exhibiting at Booth #1622.
The North American Spine Society is a global multidisciplinary medical society that utilizes education, research, and advocacy to foster the highest quality, ethical, and evidence-based spine care. NASS gathers spine professionals from around the world, offering a unique platform for Aurora to showcase its latest innovations.
At this year’s event, the company will feature its newly launched Hydra ANATOMIC. ELEVATED. RIGID. OSTEOFIXATION Facet Fusion System for facet joint-related pain or instability and DEXA-L, a stand-alone device for anterior lumbar interbody fusion (ALIF) procedures, which is part of Aurora’s patented DEXA™ Technology Platform, which offers patient-matched implants designed to align with individual bone density and T-Score, ushering in a new era of personalized spinal care.
“We are excited to attend NASS 2025 and to showcase our cutting-edge, proprietary products we've developed, especially the recently launched Hydra and DEXA-L product lines,” said Trent Northcutt, President and CEO of Aurora Spine. "We’ve worked diligently to bring new, proprietary technologies to market that are transforming spinal surgery, and we can’t wait to share them with the industry at NASS 2025."
Laszlo Garamszegi, Chief Technology Officer, added: "We’re particularly excited to showcase the DEXA-L implant line, which is the first of its kind in the world and is the first spinal implant that is a bone-mimicking™ structural implant helping doctors match the implant to the patient’s bone density and quality. These products are game-changing for spine surgeons and their patients, and we are proud to be presenting them at NASS 2025 and connecting with industry professionals in attendance."
Visit Aurora Spine at Booth #1622 to witness live demonstrations and engage with the team on how these innovations are reshaping spinal surgery.
About Aurora Spine
Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at www.aurora-spine.com or www.aurorapaincare.com .
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.
Contact:
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004
Chad Clouse
Chief Financial Officer
(760) 424-2004
Investor Relations
Adam Lowensteiner
Lytham Partners
Phone: (646) 829-9702
Email: asapf@lythampartners.com
FAQ**
What specific advantages do the Hydra ANATOMIC and DEXA-L products offered by Aurora Spine Corp ASAPF provide over traditional spinal surgery techniques?
2. How does Aurora Spine Corp ASAPF plan to leverage its patented DEXA™ Technology Platform to further enhance personalized spinal care for patients?
3. What feedback has Aurora Spine Corp ASAPF received from healthcare professionals at previous NASS meetings regarding its innovations in spinal surgery?
4. Can you elaborate on the risk factors that Aurora Spine Corp ASAPF faces, particularly related to the adoption of its new spinal implant technologies in the market?
**MWN-AI FAQ is based on asking OpenAI questions about Aurora Spine Corp (OTC: ASAPF).
NASDAQ: ASAPF
ASAPF Trading
6.6% G/L:
$0.21 Last:
2,600 Volume:
$0.2059 Open:
